¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29
±³À°ÀÏÀÚ : 2019-05-29
±³À°Àå¼Ò : ´õÄÉÀÌÈ£ÅÚ¼­¿ï ÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : 2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : À¯ÀüºÐÀÚÁø´ÜÇÐȸ  
´ã´çÀÚ : À̼Ҷó
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp1@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 17 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í Á¤È¸¿ø-8¸¸¿ø, Àü°øÀÇ-8¸¸¿ø, Àü¹®ÀÇ-12¸¸¿ø,»ê¾÷°è 15¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 08:30~09:00 2019 À¯ÀüÀÚ°Ë»ç±â°ü ÁúÆò°¡ ü°è ¹× ½É»ç ÀϹݻçÇ×  ÀÌ¿µ°æ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:00~09:30 Àü»ê ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ ÇöÀå ½Ç»ç  À¯Á¾ÇÏ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:30~09:50 ½É»çÁ¡°ËÇ¥ ¼³¸í – °Ë»ç½Ç ¿î¿µ  ¾ÈÁ¤¿­(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 09:50~10:10 ½É»çÁ¡°ËÇ¥ ¼³¸í – ºÐÀÚÀ¯Àü  ÀåÀÚÇö(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 10:10~10:30 ½É»çÁ¡°ËÇ¥ ¼³¸í – ¼¼Æ÷À¯Àü  ÀÌÁø°æ(Çѱ¹¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 09:00~09:30 Screening risk individuals in health check up  È²±Ý·Ï(¼­¿ïÀÇ°úÇבּ¸¼Ò) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 09:30~10:00 Personal identification and chimerism assay by NGS  ±èÁöÀº(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 10:00~10:30 NGS-based HLA typing  ¹ÚÀ±Èñ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 09:00~09:30 Culture & slide preparation  ¼ÕÁ¤¿Á(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 09:30~10:00 Reading & interpretation  ¼³Ã¢¾È(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 10:00~10:30 Point issues in past proficiency test  ±è°æÈñ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 11:00~12:00 Molecular drivers of inherited hematopoietic malignancies  Mark D. Ewalt(University of Colorado School of Medicine) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 12:00~13:10 Effectively manage your transplant patients with standardized & clinically validated results   ÁöÇö¼÷(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 12:00~12:30 Clinical genetic testing using NGS: Lessons learned and future direction  Ã¤Á¾Èñ(¼­¿ïÀÇ´ë Èñ±ÍÁúȯ¼¾ÅÍ) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 12:30~13:10 High throughput data analysis using dragen system  Tan, Yue Ying(Sr Bioinformatics Specialist, Illumina) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 13:10~13:40 Low level somatic mosaicism in neurologic disorders  °­ÈÆö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 13:40~14:10 The scope of hereditary tumor syndrome is expanding in the NGS era  ÀÌ¿ìâ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 14:10~14:40 Precision genomics and treatment in neuromuscular disorders  ÀÌÁ¤È¯(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 13:10~13:40 ±¹³» À¯Àü»ó´ãŬ¸®´Ð ÇöȲ  À¯Á¾ÇÏ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 13:40~14:10 À¯Àü »ó´ã Ŭ¸®´Ð ½ÃÀÛÇϱ⠠±èµµÈÆ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 14:10~14:40 À¯Àü »ó´ã Ŭ¸®´Ð ¿î¿µ A, B, C  ½Å°æÈ­(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 13:10~13:40 Data analysis of DNA-Seq  ±è¼±¿µ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 13:40~14:10 Data analysis of RNA-Seq  ÀÌÁØÇü(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 14:10~14:40 Deep learning for genomics  ¼º¹®¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 15:10~15:40 Epilepsy-related disorders  ÀÓº´Âù(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 15:40~16:10 NGS-guided precision medicine in inherited eye disorders  ÇÑÁø¿ì(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-29 ±×·£µåº¼·ëB 16:10~16:40 Immune deficiency  ±è¿¹Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 15:10~15:40 Urea cycle disorders and hyperammonemia  ÀÌ°æÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 15:40~16:10 Disorders of carnitine cycle and fatty acid oxidation disorders  ±è¼¼¸²(³ì½ÊÀÚÀÇ·áÀç´Ü) 
±³À°½Ã°£ 05-29 ±Ý°­È¦A 16:10~16:40 Galactosemia  ¾È¼±Çö(¼­¿ïÀÇ°úÇבּ¸¼Ò) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 15:10~15:40 À¯ÀüÀÚÀç¹è¿­ÀÇ Á¤¼ºÀû °ËÃâ  ¼­ÀÚ¿µ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 15:40~16:10 À¯ÀüÀÚÀç¹è¿­ÀÇ Á¤·®Àû °ËÃâ  Á¶¿µ¿í(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-29 Å©¸®½ºÅ»º¼·ë 16:10~16:40 ¿°±â¼­¿­ºÐ¼®À» ÀÌ¿ëÇÑ µ¹¿¬º¯ÀÌ °ËÃâ  ±è¹Ì¿µ(ÇѸ²ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ Çмú´ëȸ : 2019-05-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼øõÇâ´ëÇб³Ãµ¾Èº´¿ø ½Å»ý¾Æ¼Ò»ý¼ú : 2019-05-29
´ÙÀ½±Û Ãæ³²´ëÇб³º´¿ø Multidiciplinary approach to Developmental Epileptic Encephalopathy : 2019-05-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20679 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Ç÷°üÁúȯ, À̽ļö¼ú) : 2024-06-13 0 0 16:59:33
20678 ¼­¿ï ±¸·Î±¸ÀÇ»çȸ 2024³âµµ Á¦2Â÷ ¿¬¼ö±³À° : 2024-06-11 0 0 16:57:52
20677 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-06-10 0 0 16:56:33
20676 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼ÒÈ­±â³»°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-09 0 0 16:54:30
20675 Ãæ³² 2024³â »ó¹Ý±â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ´ëÀü¼¼Á¾ÃæûÁöȸ ¿¬¼ö±³À° : 2024-06-08 0 0 16:52:21
20674 ºÎ»ê 2024³â Á¦ 7ȸ ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-08 0 0 16:51:14
20673 ´ë±¸ Á¦24Â÷ ´ë±¸°æºÏ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-06-08 0 0 16:50:00
20672 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 1Â÷ : 2024-06-08 0 0 16:48:24
20671 ¼­¿ï »ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú SMC MCS Symposium 2024 : 2024-06-08 0 0 16:47:19
20670 ¼­¿ï 2024 ´ëÇѵðÁöÅÐÀÓ»óÀÇÇÐȸ ÇÏ°è Çмú´ëȸ : 2024-06-02 0 0 16:43:35
20669 ¼­¿ï Á¦6ȸ ´ëÇѼö¼úÁ߽Űæ°è°¨½ÃÇÐȸ ¿¬¼ö°­Á : 2024-06-01 0 0 16:41:37
20668 ºÎ»ê ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 7th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2024-06-01 0 0 16:39:45
20667 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 2024³â ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2024-06-01 0 1 16:38:13
20666 ´ëÀü 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ´ëÀü¼¼Á¾Áöȸ Ãá°èÇмú´ëȸ(°íÇ÷¾Ð, °ú¹Î¼º ÀåÁõÈıº, ¼ö¸éÀå¾Ö) : 2024-05-30 0 1 16:35:24
20665 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2024-05-30 0 0 16:30:57
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷